Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$49.7 - $57.71 $477,120 - $554,016
9,600 Added 13.01%
83,400 $4.25 Million
Q3 2022

Nov 09, 2022

BUY
$53.86 - $66.8 $839,785 - $1.04 Million
15,592 Added 26.79%
73,800 $4 Million
Q2 2022

Aug 09, 2022

BUY
$63.83 - $80.0 $217,022 - $272,000
3,400 Added 6.2%
58,208 $3.76 Million
Q1 2022

May 12, 2022

BUY
$76.85 - $89.45 $276,660 - $322,020
3,600 Added 7.03%
54,808 $4.25 Million
Q4 2021

Feb 11, 2022

BUY
$74.57 - $87.19 $253,537 - $296,446
3,400 Added 7.11%
51,208 $4.4 Million
Q3 2021

Nov 09, 2021

BUY
$73.77 - $83.61 $3.53 Million - $4 Million
47,800 Added 597500.0%
47,808 $3.85 Million
Q2 2021

Aug 09, 2021

SELL
$80.5 - $88.01 $3.65 Million - $3.99 Million
-45,307 Reduced 99.98%
8 $1,000
Q1 2021

May 13, 2021

BUY
$76.38 - $86.03 $115,715 - $130,335
1,515 Added 3.46%
45,315 $3.82 Million
Q4 2020

Feb 11, 2021

BUY
$75.39 - $82.36 $474,957 - $518,868
6,300 Added 16.8%
43,800 $3.52 Million
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $211,491 - $244,971
2,700 Added 7.76%
37,500 $3.02 Million
Q2 2020

Aug 04, 2020

BUY
$78.66 - $94.14 $2.73 Million - $3.27 Million
34,700 Added 34700.0%
34,800 $3 Million
Q1 2020

May 12, 2020

BUY
$71.57 - $93.3 $7,156 - $9,330
100 New
100 $8,000
Q3 2019

Nov 13, 2019

SELL
$81.4 - $89.78 $2.65 Million - $2.93 Million
-32,600 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$73.44 - $82.41 $36,720 - $41,205
-500 Reduced 1.51%
32,600 $2.67 Million
Q1 2019

May 08, 2019

BUY
$64.48 - $81.31 $174,096 - $219,537
2,700 Added 8.88%
33,100 $2.69 Million
Q4 2018

Feb 01, 2019

BUY
$61.45 - $77.8 $1.78 Million - $2.25 Million
28,900 Added 1926.67%
30,400 $2 Million
Q4 2017

Feb 12, 2018

BUY
$61.45 - $66.05 $92,175 - $99,075
1,500
1,500 $97,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Providence Capital Advisors, LLC Portfolio

Follow Providence Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.